EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $511,000 | -65.4% | 60,008 | -64.0% | 0.00% | -72.7% |
Q1 2021 | $1,476,000 | -41.0% | 166,726 | -18.1% | 0.01% | -50.0% |
Q4 2020 | $2,503,000 | +5.8% | 203,644 | -29.9% | 0.02% | -12.0% |
Q3 2020 | $2,366,000 | +34.6% | 290,698 | +58.7% | 0.02% | +31.6% |
Q2 2020 | $1,758,000 | +207.9% | 183,120 | +118.1% | 0.02% | +171.4% |
Q1 2020 | $571,000 | +79.6% | 83,979 | +293.2% | 0.01% | +133.3% |
Q4 2019 | $318,000 | +43.2% | 21,360 | -1.4% | 0.00% | 0.0% |
Q3 2019 | $222,000 | -11.6% | 21,660 | +45.0% | 0.00% | -40.0% |
Q1 2016 | $251,000 | – | 14,938 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
RA Capital Management | 354,200 | $4,056,000 | 0.50% |
DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |